unknown
Stage
2020
Founded
1
Investors
About
Diffuse Bio develops generative AI models and an automated software platform for protein design, aiming to engineer novel protein binders and therapeutics. The company also conducts in-house assay development and data generation to bridge AI research and biological validation.
Explore Diffuse Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.